Allena Stock Alpha and Beta Analysis

ALNA
 Stock
  

USD 0.026  0.0007  2.77%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Allena Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Allena Pharmaceuticals over a specified time horizon. Remember, high Allena Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please continue to Trending Equities.
  
Please note that although Allena Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Allena Pharmaceuticals did 1.08  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Allena Pharmaceuticals stock's relative risk over its benchmark. Allena Pharmaceuticals has a beta of 0.15  . Let's try to break down what Allena's beta means in this case. As returns on the market increase, Allena Pharmaceuticals returns are expected to increase less than the market. However, during the bear market, the loss on holding Allena Pharmaceuticals will be expected to be smaller as well.
.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Allena Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Allena Pharmaceuticals market risk premium is the additional return an investor will receive from holding Allena Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Allena Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Allena Pharmaceuticals' performance over market.
α-1.08   β0.15
90 days against DJI

Allena Pharmaceuticals Fundamentals Vs Peers

Comparing Allena Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Allena Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Allena Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Allena Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Allena Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Allena Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Allena Pharmaceuticals to competition
FundamentalsAllena PharmaceuticalsPeer Average
Return On Equity(278.14) %(0.31) %
Return On Asset(96.04) %(0.14) %
Current Valuation8.46 M16.62 B
Shares Outstanding85.37 M571.82 M
Shares Owned by Insiders1.15 %10.09 %
Shares Owned by Institutions7.59 %39.21 %
Number of Shares Shorted8.59 M4.71 M

Allena Pharmaceuticals Opportunities

Allena Pharmaceuticals Return and Market Media

The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Termination of Agreement06/28/2022
2
EPS Estimate06/30/2022
3
Financial Statements07/05/2022
4
Financial Statements07/08/2022
5
Financial Statements07/11/2022
6
Unclassified Event07/12/2022
7
Filing08/04/2022
8
Financial Statements08/11/2022
9
EPS Reported08/15/2022
10
Filing08/24/2022
11
Filing09/02/2022

About Allena Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Allena or other stocks. Alpha measures the amount that position in Allena Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Allena Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Allena Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Allena Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Allena Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Allena Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Allena Pharmaceuticals' management manipulating its earnings.
Upcoming Quarterly Report8th of March 2022
Next Financial Report10th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End8th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Allena Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please continue to Trending Equities. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Tools for Allena Stock

When running Allena Pharmaceuticals price analysis, check to measure Allena Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allena Pharmaceuticals is operating at the current time. Most of Allena Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Allena Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Allena Pharmaceuticals' price. Additionally, you may evaluate how the addition of Allena Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go